| 1 |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 report [EB/OL].
URL
|
| 2 |
Amano H, Murata K, Matsunaga H, et al. p38 Mitogen-activated protein kinase accelerates emphysema in mouse model of chronic obstructive pulmonary disease [J]. J Recept Signal Transduct Res, 2014, 34(4): 299-306.
|
| 3 |
Kostikas K, Bakakos P, Papiris S, et al. Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application? [J]. Curr Drug Targets, 2013, 14(2): 177-191.
|
| 4 |
Guiot J, Struman I, Louis E, et al. Exosomal miRNAs in lung diseases: from biologic function to therapeutic targets [J]. J Clin Med, 2019, 8(9): 1345-1372.
|
| 5 |
O'Farrell HE, Yang IA. Extracellular vesicles in chronic obstructive pulmonary disease (COPD) [J]. J Thorac Dis, 2019, 11(Suppl 17): S2141-S2154.
|
| 6 |
Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release [J]. Cell Mol Life Sci, 2018,75(2): 193-208.
|
| 7 |
Muralidharan-Chari V, Clancy JW, Sedgwick A, et al. Microvesicles: mediators of extracellular communication during cancer progression [J]. J Cell Sci, 2010, 123(Pt 10): 1603-1611.
|
| 8 |
Bebelman MP, Smit MJ, Pegtel DM, et al. Biogenesis and function of extracellular vesicles in cancer [J]. Pharmacol Ther, 2018, 188: 1-11.
|
| 9 |
Benedikter BJ, Wouters EFM, Savelkoul PHM, et al. Extracellular vesicles released in response to respiratory exposures: implications for chronic disease [J]. J Toxicol Environ Health B Crit Rev, 2018, 21(3): 142-160.
|
| 10 |
Akers JC, Gonda D, Kim R, et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies [J]. J Neurooncol, 2013, 113(1): 1-11.
|
| 11 |
Andaloussi SEL, Mäger I, Breakefield XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities [J]. Nat Rev Drug Discov, 2013, 12(5): 347-357.
|
| 12 |
Fujita Y, Kosaka N, Araya J, et al. Extracellular vesicles in lung microenvironment and pathogenesis [J]. Trends Mol Med, 2015, 21(9): 533-542.
|
| 13 |
Cordazzo C, Petrini S, Neri T, et al. Rapid shedding of proinflammatory microparticles by human mononuclear cells exposed to cigarette smoke is dependent on Ca2+ mobilization [J]. Inflamm Res, 2014, 63(7): 539-547.
|
| 14 |
Anand PK, Anand E, Bleck CKE, et al. Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria [J]. PLoS One, 2010, 5(4): e10136.
|
| 15 |
Fujita Y, Kadota T, Araya J, et al. Extracellular vesicles: new players in lung immunity [J]. Am J Respir Cell Mol Biol, 2018, 58(5): 560-565.
|
| 16 |
Genschmer KR, Russell DW, Lal C, et al. Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung [J]. Cell, 2019, 176(1-2): 113-126.
|
| 17 |
Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to go [J]. Cell, 2016, 164(6): 1226-1232.
|
| 18 |
Ortiz-Quintero B. Cell-free microRNAs in blood and other body fluids, as cancer biomarkers [J]. Cell Prolif, 2016, 49(3): 281-303.
|
| 19 |
Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs [J]. Genome Res, 2009, 19(1): 92-105.
|
| 20 |
Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers [J]. PLoS One, 2008, 3(9): e3148.
|
| 21 |
Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis [J]. Cancer Sci, 2010, 101(10): 2087-2092.
|
| 22 |
Ryu AR, Kim DH, Kim E, et al. The potential roles of extracellular vesicles in cigarette smoke-associated diseases [J]. Oxidative Med Cell Longev, 2018, 2018: 1-8.
|
| 23 |
Serban KA, Rezania S, Petrusca DN, et al. Structural and functional characterization of endothelial microparticles released by cigarette smoke [J]. Sci Rep, 2016, 6: 31596.
|
| 24 |
Sundar IK, Li D, Rahman I. Small RNA-sequence analysis of plasma-derived extracellular vesicle miRNAs in smokers and patients with chronic obstructive pulmonary disease as circulating biomarkers [J]. J Extracell Vesicles, 2019, 8(1): 1684816.
|
| 25 |
Sundar IK, Li D, Rahman I. Proteomic analysis of plasma-derived extracellular vesicles in smokers and patients with chornic obstructive pulmonary disease [J]. ACS Omega, 2019, 4(6): 10649-10661.
|
| 26 |
Singh KP, Maremanda KP, Li D, et al. Exosomal microRNAs are novel circulating biomarkers in cigarette, waterpipe smokers, E-cigarette users and dual smokers [J]. BMC Med Genomics, 2020, 13(1): 128.
|
| 27 |
Wang H, Guan X, Tu Y, et al. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN [J]. J Exp Clin Cancer Res, 2015, 34(1): 59.
|
| 28 |
Benedikter BJ, Volgers C, Van Eijck PH, et al. Cigarette smoke extract induced exosome release is mediated by depletion of exofacial thiols and can be inhibited by thiol- antioxidants [J]. Free Radic Biol Med, 2017, 108: 334-344.
|
| 29 |
Kadota T, Fujita Y, Yoshioka Y, et al. Emerging role of extracellular vesicles as a senescence- associated secretory phenotype: Insights into the pathophysiology of lung diseases [J]. Mol Asp Med, 2018, 60: 92-103.
|
| 30 |
Heliot A, Landkocz Y, Roy Saint-Georges F, et al. Smoker extracellular vesicles influence status of human bronchial epithelial cells [J]. Int J Hyg Environ Health, 2017, 220(2Pt B): 445-454.
|
| 31 |
Xu H, Ling M, Xue J, et al. Exosomal microRNA-21 derived from bronchial epithelial cells is involved in aberrant epithelium-fibroblast cross-talk in COPD induced by cigarette smoking [J]. Theranostics, 2018, 8(19): 5419-5433.
|
| 32 |
Feller D, Kun J, Ruzsics I, et al. Cigarette smoke-induced pulmonary inflammation becomes systemic by circulating extracellular vesicles containing Wnt5a and inflammatory cytokines [J]. Front Immunol, 2018, 9: 1724.
|
| 33 |
Fujita Y, Kadota T, Araya J, et al. Extracellular vesicles: new players in lung immunity [J]. Am J Respir Cell Mol Biol, 2018, 58(5): 560-565.
|
| 34 |
Tan DBA, Armitage J, Teo TH, et al. Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation [J]. Respir Med, 2017, 132: 261-264.
|
| 35 |
Fujita Y, Araya J, Ito S, et al. Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesis [J]. J Extracell Vesicles, 2015, 4: 28388.
|
| 36 |
Hinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling [J]. Am J Pathol, 2012, 180(4): 1340-1355.
|
| 37 |
Michalik M, Wojcik-Pszczola K,Paw M, et al. Fibroblast-to-myofibroblast transition in bronchial asthma [J]. Cell Mol Life Sci, 2018, 75(21): 3943-3961.
|
| 38 |
Burke H, Heinson A, Freeman A, et al. Late breaking abstract-differentially expressed exosomal miRNAs target key inflammatory pathways in COPD[C]// ERS International Congress 2018 abstracts. 2018.
|